** = Publikationen gelistet in SCI/SSCI/Pubmed
** Esparta, O; Rosskopf, K; Böhm, P; Hoetzenecker, K; Kwapiszewska, G; Marsh, L
Immune cell interaction in Pulmonary Arterial Hypertension
EUR J IMMUNOL. 2024; 54: 881-881.
[Poster]
Web of Science
** Sperl, D; Benesch, M; Posch, U; Rosskopf, K; Strenger, V; Tschauner, S; Seidel, MG; Schwinger, W
SUCCESSFUL THIRD ALLOGENEIC STEM CELL TRANSPLANTATION FOLLOWING TWO GRAFT REJECTIONS IN A PATIENT WITH CHRONIC GRANULOMATOUS DISEASE AND HEPATIC/PARAPHRENIC ABSCESSES
BONE MARROW TRANSPL. 2024; 59: 416-416.-50th EBMT Annual Meeting; APR 14-17, 2024; Glasgow, SCOTLAND.
[Poster]
Web of Science
** Krizanic, KK; Pruller, F; Rosskopf, K; Payrat, JM; Andresen, S; Schlenke, P
Preparation and Storage of Cryoprecipitate Derived from Amotosalen and UVA-Treated Apheresis Plasma and Assessment of In Vitro Quality Parameters
PATHOGENS. 2022; 11(7): 805
Doi: 10.3390/pathogens11070805
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Sperl, D; Lang, P; Benesch, M; Bainschab, A; Urban, C; Wilfing, R; Feuchtinger, T; Döring, M; Seitz, C; Strenger, V; Lackner, H; Seidel, MG; Perwein, T; Handgretinger, R; Sipurzynski, S; Rosskopf, K; Schwinger, W
Immunological recovery following HLA-matched CD3+ TCR αß+/CD19+ depleted hematopoietic stem cell transplantation in children.
Pediatr Transplant. 2022; 26(5):e14285
Doi: 10.1111/petr.14285
Web of Science
PubMed
FullText
FullText_MUG
** Gaksch, L; Huber-Krassnitzer, B; Uhl, B; Bainschab, A; Sifferlinger, IA; Sill, H; Schlenke, P; Rosskopf, K; Beham-Schmid, C; Neumeister, P; Greinix, HT
Autologous stem cell boost for prolonged severe cytopenia after treatment with cd19-car-t-cells for refractory diffuse large b-cell lymphoma -two case reports
BONE MARROW TRANSPL. 2022; 57(SUPPL 1): 141-142.
[Poster]
Web of Science
FullText
** Hatzl, S; Posch, F; Sareban, N; Stradner, M; Rosskopf, K; Reisinger, AC; Eller, P; Schörghuber, M; Toller, W; Sloup, Z; Prüller, F; Gütl, K; Pilz, S; Rosenkranz, AR; Greinix, HT; Krause, R; Schlenke, P; Schilcher, G
Convalescent plasma therapy and mortality in COVID-19 patients admitted to the ICU: a prospective observational study.
Ann Intensive Care. 2021; 11(1): 73
Doi: 10.1186/s13613-021-00867-9
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Guetl, K; Moazedi-Fuerst, F; Rosskopf, K; Brodmann, M; Krause, R; Eller, P; Wilhelmer, P; Eisner, F; Sareban, N; Schlenke, P; Kessler, HH; Steinmetz, I; Redlberger-Fritz, M; Stiasny, K; Stradner, M
SARS-CoV-2 positive virus culture 7 weeks after onset of COVID-19 in an immunocompromised patient suffering from X chromosome-linked agammaglobulinemia.
J Infect. 2021; 82(3):414-451
Doi: 10.1016/j.jinf.2020.10.025
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Krizanic, KK; Rosskopf, K; Payrat, JM; Andresen, S; Pruller, F; Schlenke, P
Stability of Cryoprecipitate from Pathogen Reduced Apheresis Plasma: 2-year Frozen Storage Post-production and 120 Hours Storage at Room Temperature
TRANSFUSION. 2021; 61: 72A-72A.
[Keynote lecture]
Web of Science
** Rosskopf, K; Helmberg, W; Schlenke, P
Pathogen reduction of double-dose platelet concentrates from pools of eight buffy coats: Product quality, safety, and economic aspects.
Transfusion. 2020; 60(9):2058-2066
Doi: 10.1111/trf.15926
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Rosskopf, K; Sipurzynski, S; Posch, U; Schwinger, W; Torreiter, P; Kovacic, K; Schlenke, P
RED BLOOD CELL DEPLETION OF BONE MARROW: COMPARISON OF TWO CELL SEPARATORS AND FIRST EXPERIENCE WITH SMALL VOLUME GRAFTS
TRANSPL INT. 2018; 31: 20-20.
[Oral Communication]
Web of Science
** Egger, M; Kurath, S; Strenger, V; Grisold, A; Schlenke, P; Rosskopf, K; Krakowitzky, P; Lackner, H; Schwinger, W; Urban, C
Klebsiella Oxytoca Bacteremia Induced Septic Shock following Platelet Transfusion.
Klin Padiatr. 2017; 229(5):304-305
Doi: 10.1055/s-0043-116850
Web of Science
PubMed
FullText
FullText_MUG
** Prüller, F; Rosskopf, K; Mangge, H; Mahla, E; von Lewinski, D; Weiss, EC; Riegler, A; Enko, D
Implementation of buffy-coat-derived pooled platelet concentrates for internal quality control of light transmission aggregometry: a proof of concept study.
J Thromb Haemost. 2017; 15(12):2443-2450
Doi: 10.1111/jth.13870
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Worel, N; Fritsch, G; Agis, H; Böhm, A; Engelich, G; Leitner, GC; Geissler, K; Gleixner, K; Kalhs, P; Buxhofer-Ausch, V; Keil, F; Kopetzky, G; Mayr, V; Rabitsch, W; Reisner, R; Rosskopf, K; Ruckser, R; Zoghlami, C; Zojer, N; Greinix, HT
Plerixafor as preemptive strategy results in high success rates in autologous stem cell mobilization failure.
J Clin Apher. 2017; 32(4):224-234
Doi: 10.1002/jca.21496
Web of Science
PubMed
FullText
FullText_MUG
** Macher, S; Wagner, T; Rosskopf, K; Reiterer, F; Csapo, B; Schlenke, P; Klaritsch, P
Severe case of fetal hemolytic disease caused by anti-C(w) requiring serial intrauterine transfusions complicated by pancytopenia and cholestasis.
Transfusion. 2016; 56(1):80-83
Doi: 10.1111/trf.13367
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
** Macher, S; Sipurzynski-Budraβ, S; Rosskopf, K; Semmelrock, M; Prüller, F; Griesbacher, A; Lanzer, G; Schallmoser, K
Influence of multicomponent apheresis on donors' haematological and coagulation parameters, iron storage and platelet function.
Vox Sang. 2012; 103(3):194-200
Doi: 10.1111/j.1423-0410.2012.01609.x
Web of Science
PubMed
FullText
FullText_MUG
** Rosskopf, K; Ragg, SJ; Worel, N; Gromme, M; Preijers, FW; Braakman, E; Schuurhuis, GJ; van Riet, I; Wendel, S; Fontao-Wendel, R; Lazar, A; Goldman, M; Halpenny, M; Giulivi, A; Letcher, B; McGann, L; Korhonen, M; Arvola, A; Humpe, A; Buwitt-Beckmann, U; Wiesneth, M; Schauwecker, P; Schrezenmeier, H; Bönig, H; Henschler, R; Seifried, E; Accorsi, P; Bonfini, T; Takanashi, M; van Beckhoven, JM; Brand, A; Gounder, D; Wong, A; Dooccey, R; Forrest, E; Galea, G; Smythe, J; Pawson, R; Reems, JA; Oh, J; Reesink, HW; Panzer, S
Quality controls of cryopreserved haematopoietic progenitor cells (peripheral blood, cord blood, bone marrow).
VOX SANG. 2011; 101(3): 255-275.
Doi: 10.1111/j.1423-0410.2011.01471.x
Web of Science
PubMed
FullText
FullText_MUG
** Worel, N; Rosskopf, K; Neumeister, P; Kasparu, H; Nachbaur, D; Russ, G; Namberger, K; Witt, V; Schloegl, E; Zojer, N; Linkesch, W; Kalhs, P; Greinix, HT
Plerixafor and granulocyte-colony-stimulating factor (G-CSF) in patients with lymphoma and multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy for autologous hematopoietic stem cell mobilization: the Austrian experience on a named patient program.
Transfusion. 2011; 51(5):968-975
Doi: 10.1111/j.1537-2995.2010.02896.x
Web of Science
PubMed
FullText
FullText_MUG
** Rosskopf, A
A NEW PRESTORAGE LEUCOCYTE REDUCTION FILTER FOR RED BLOOD CELL CONCENTRATES LEADS TO SIGNIFICANT LOWER LEUCOCYTE CONTAMINATION
VOX SANG. 2011; 101: 65-66.
Web of Science
** Macher, S; Sipurzynski-Budraß, S; Rosskopf, K; Rohde, E; Griesbacher, A; Groselj-Strele, A; Lanzer, G; Schallmoser, K
Function and activation state of platelets in vitro depend on apheresis modality.
Vox Sang. 2010; 99(4): 332-340.
Doi: 10.1111/j.1423-0410.2010.01353.x
Web of Science
PubMed
FullText
FullText_MUG
** Macher, S; Sipurzynski, S; Rosskopf, K; Rohde, E; Groselj-Strele, A; Griesbacher, A; Lanzer, G; Schallmoser, K
HIGHER ACTIVATION STATE OF PLATELETS AFTER APHERESIS: EVIDENCE FOR AN IMPACT OF LOW VOLUME CENTRIFUGATION
VOX SANG. 2010; 99: 168-168.
[Poster]
Web of Science
** Macher, S; Sipurzynski, S; Rosskopf, K; Rohde, E; Groselj-Strele, A; Griesbacher, A; Lanzer, G; Schallmoser, K
HIGH ACTIVATION STATE OF APHERESIS PLATELETS AFTER LOW VOLUME CENTRIFUGATION DURING MULTICOMPONENT COLLECTION
HAEMATOL-HEMATOL J. 2010; 95: 1058-
[Poster]
Web of Science
** Macher, S; Sipurzynski, S; Rosskopf, K; Rohde, E; Groselj-Strele, A; Griesbacher, A; Lanzer, G; Schallmoser, K
High ex vivo activation state of platelets after apheresis due to low-volume centrifugation during multicomponent collection
BONE MARROW TRANSPLANT. 2010; 45: S382-S383.
[Poster]
Web of Science
** Sovinz, P; Schwinger, W; Lackner, H; Benesch, M; Nebl, A; Raicht, A; Sipurzynski, S; Rosskopf, K; Urban, C
Short-term cryopreserved allogeneic stem cells to optimize graft and recipient conditions in children
BONE MARROW TRANSPLANT. 2010; 45: S272-S273.
[Poster]
Web of Science
** Worel, N; Rosskopf, K; Agis, H; Nachbaur, D; Kasparu, H; Russ, G; Keil, F; Linkesch, W; Greinix, H
PLERIXAFOR PLUS G-CSF CAN SUCCESSFULLY MOBILIZE CD34+CELLS FROM PATIENTS WHO HAVE PREVIOUSLY FAILED CHEMOTHERAPY AND/OR CYTOKINE MOBILIZATION: THE COMPASSIONATE USE EXPERIENCE IN AUSTRIA
VOX SANG. 2010; 99: 9-10.
[Poster]
Web of Science
** Worel, N; Rosskopf, K; Nachbaur, D; Kasparu, H; Russ, G; Namberger, K; Leitner, G; Kalhs, P; Schogl, E; Witt, V; Greinix, H; Keil, F; Linkesch, W
Plerixafor plus G-CSF can successfully mobilize CD34+cells from patients who have previously failed chemotherapy and/or cytokine mobilization: the compassionate use experience in Austria
BONE MARROW TRANSPLANT. 2010; 45: S318-S318. -36th Annual Meeting of the European Group for Blood and Marrow Transplantation; MAR 21-24, 2010; Vienna, AUSTRIA.
[Poster]
Web of Science
** Macher, S; Schallmoser, K; Sipurzynski, S; Rosskopf, K; Lanzer, G
Multicomponent apheresis with two different cell separators: Comparison of platelet function and metabolic parameters
TRANSFUSION. 2006; 46(9):41A-41A.-American Association of Blood Banks (AABB) 59th Annual Meeting; OCT 21-24, 2006; Miami Beach, Florida, USA.
[Poster]
Web of Science
** Schallmoser, K; Macher, S; Sipurzynski, S; Rosskopf, K; Lanzer, G
Activation markers and function of platelets collected by multicomponent apheresis with two different devices during seven days of storage
TRANSFUSION. 2006; 46(9):30A-31A.-American Association of Blood Banks (AABB) 59th Annual Meeting; OCT 21-24, 2006; Miami Beach, Florida, USA.
[Oral Communication]
Web of Science
** Schallmoser, K; Rosskopf, K; Macher, S; Stubenrauch, M; Lanzer, G
Automatic platelet concentrate preparation induces higher recovery of platelets
BONE MARROW TRANSPLANT. 37: S301-S302.-32nd Annual Meeting of the European-Group-for-Blood-and-Morrow-Transplantation/22nd Meeting of the EBMT-Nures-Group/5th Meeting of the EMBT-Data-Management-Group; MAR 19-22, 2006; Hamburg, GERMANY.
[Poster]
Web of Science
** Macher, S; Schallmoser, K; Staber, P; Neumeister, P; Rosskopf, K; Posch, U; Panzer, S; Lanzer, G
Severe immune thrombocytopenia due to HPA-1 a host-derived antibodies after non-myeloablative allogeneic hematopoetic stem cell transplantation for multiple myeloma
TRANSFUSION 2005 45: 114A-114A.
Web of Science
** Schallmoser, K; Rosskopf, K; Macher, S; Stubenrauch, M; Lanzer, G
Comparison of platelet concentrates from pooled buffy coats prepared automatically by the OrbiSac system and conventionally produced platelet concentrates
TRANSFUSION 2005 45: 67A-68A.
Web of Science
** Rosskopf, K; Sipurzynski, S; Gilli, R; Posch, U; Olipitz, W; Linkesch, W; Gehrer, M; Wagner, T; Lanzer, G
Marked reduction of bacterial contamination rate in peripheral blood progenitor cell concentrates after installation of a labaratory according to GMP
BONE MARROW TRANSPLANT. 2003; 31: S200-S200.
Web of Science
** Rosskopf, K; Wagner, T; Schallmoser, K; Eibl, M; Brezinschek, R; Linkesch, W; Lanzer, G
Clots In cryopreserved autologous peripheral blood stem cell concentrates (Pbsc) at the time of thawing - Possible causes and prophylactic strategies
BONE MARROW TRANSPLANT. 2002; 29: S203-S203.
Web of Science
** Gilli, R; Macher, S; Posch, U; Rosskopf, K; Schallmoser, K; Sipurzynski, S; Wagner, T; Wasler, A; Tscheliessnigg, K; Lanzer, G
Feasibility of extracorporal photopheresis in patients after heart transplantation
TRANSFUSION 2001 41: 43S-43S.
Web of Science
** Schallmoser, K; Wagner, T; Rosskopf, K; Macher, S; Posch, U; Gilli, R; Sipurzynski, S; Lanzer, G
Alloimmunization after RhD-incompatible platelet transfusions
TRANSFUSION. 2001; 41: 105S-105S.-54th Annual Meeting; OKT 13-17, 2001; San Antonio, TX, USA.
Web of Science
** Wagner, T; Schallmoser, K; Vadon, M; Rosskopf, K; Gilli, R; Lanzer, G
Collection efficacy, residual white blood cell count and platelet activation markers: Comparison of MCS LDP C vs. MCS LDP C2
TRANSFUSION 2001 41: 47S-47S.
Web of Science
PubMed
** Rosskopf, K; Wagner, T; Helmberg, W; Sipurzynski, S; Gilli, R; Eibl, M; Linkesch, W; Höfler, G; Lanzer, G
CD34 positive compared to one-step positive-negative selection of autologous peripheral blood stem cells (PBSC)
TRANSFUSION 2000 40: 110S-110S.
Web of Science